Record overview
Status and phase
Status: RECRUITING
Phase: PHASE2
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Condition: Triple-Negative Breast Cancer
NCT06492005
A Clinical Study of 9MW2821 (and PD-1 Inhibitor) in Locally Advanced or Metastatic Triple-Negative Breast Cancer
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal | long_recruitment_duration_signal
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.